By downloading AML-related data from The Cancer Genome Atlas database and performing differential analysis using edgeR, Huang et al. found APOE to be the hub gene in patients with a mutation of TP53, which is the driving gene of AML [44]. The gene discussed is APOE; the disease is acute myeloid leukemia.